The company has issued more shares over this period, which dilutes each existing shareholder’s stake.
Diluted shares outstanding: 60.3M (2018) → 813.2M (2022)
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+117.9% YoY
YoY Growth Rate
Revenue accelerating
+300.0% YoY
YoY Growth Rate
EPS growth accelerating
$0/ year
0.0% of revenue
Below sector average (4%)
Research and development spending
Cash flow positive
$651,026 cash & investments
Quarterly Free Cash Flow
→ Burn rate stable
Company generates more cash than it spends — no dilution risk from fundraising
CannLabs grew revenue 118% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Earnings per share down more than 10%. Either a bad year, or a real decline.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Interest coverage above 8. Profits cover interest many times over.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
P/E under 10. The price tag is small relative to last year's profit.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
